171 related articles for article (PubMed ID: 29633283)
1. T-cell profiles elicited by Toxoplasma gondii in acutely/chronically infected humans.
Silva-Gutierrez N; Bahsas Zaky R; Bouchard M; Teran Angel G; Amoroso A; Peterson DL; Salmen S
Parasite Immunol; 2018 Jun; 40(6):e12532. PubMed ID: 29633283
[TBL] [Abstract][Full Text] [Related]
2. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
[TBL] [Abstract][Full Text] [Related]
3. The optimal mixture of Toxoplasma gondii recombinant antigens (GRA1, P22, ROP1) for diagnosis of ovine toxoplasmosis.
Holec-Gąsior L; Ferra B; Hiszczyńska-Sawicka E; Kur J
Vet Parasitol; 2014 Dec; 206(3-4):146-52. PubMed ID: 25300561
[TBL] [Abstract][Full Text] [Related]
4. The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti-Toxoplasma gondii antibodies in mouse and human sera.
Ferra BT; Holec-Gąsior L; Gatkowska J; Dziadek B; Dzitko K; Grąźlewska W; Lautenbach D
PLoS One; 2019; 14(6):e0217866. PubMed ID: 31170254
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.
Washino T; Moroda M; Iwakura Y; Aosai F
Infect Immun; 2012 Apr; 80(4):1437-44. PubMed ID: 22290145
[TBL] [Abstract][Full Text] [Related]
6. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
[TBL] [Abstract][Full Text] [Related]
7. Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts.
Döşkaya M; Liang L; Jain A; Can H; Gülçe İz S; Felgner PL; Değirmenci Döşkaya A; Davies DH; Gürüz AY
Parasit Vectors; 2018 Jul; 11(1):393. PubMed ID: 29973272
[TBL] [Abstract][Full Text] [Related]
8. Peptide-Based Monoclonal Antibody Production Against SAG1 (P30) Protein of
Naghi Vishteh M; Javadi Mamaghani A; Rashidi S; Seyyed Tabaei SJ; Jeddi-Tehrani M
Monoclon Antib Immunodiagn Immunother; 2020 Apr; 39(2):51-56. PubMed ID: 32216700
[No Abstract] [Full Text] [Related]
9. Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.
Fatoohi AF; Cozon GJ; Greenland T; Ferrandiz J; Bienvenu J; Picot S; Peyron F
Clin Diagn Lab Immunol; 2002 May; 9(3):704-7. PubMed ID: 11986281
[TBL] [Abstract][Full Text] [Related]
10. New recombinant chimeric antigens, P35-MAG1, MIC1-ROP1, and MAG1-ROP1, for the serodiagnosis of human toxoplasmosis.
Drapała D; Holec-Gąsior L; Kur J
Diagn Microbiol Infect Dis; 2015 May; 82(1):34-9. PubMed ID: 25702523
[TBL] [Abstract][Full Text] [Related]
11. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
[TBL] [Abstract][Full Text] [Related]
13. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.
Zhou H; Min J; Zhao Q; Gu Q; Cong H; Li Y; He S
Vaccine; 2012 Feb; 30(10):1800-6. PubMed ID: 22240340
[TBL] [Abstract][Full Text] [Related]
14. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development.
Prigione I; Facchetti P; Lecordier L; Deslée D; Chiesa S; Cesbron-Delauw MF; Pistoia V
J Immunol; 2000 Apr; 164(7):3741-8. PubMed ID: 10725733
[TBL] [Abstract][Full Text] [Related]
15. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
17. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154.
Hiszczyńska-Sawicka E; Li H; Xu JB; Holec-Gąsior L; Kur J; Sedcole R; Bickerstaffe R; Stankiewicz M
Vet Parasitol; 2011 Dec; 183(1-2):72-8. PubMed ID: 21742437
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
19. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
